(Q38802959)

6 September 2017

1 reference

23 October 2022

A new role of neuraminidase (NA) in the influenza virus life cycle: implication for developing NA inhibitors with novel mechanism of action (English)

1 reference

6 September 2017

4

Shibo Jiang

1 reference

6 September 2017

3

Lanying Du

1 reference

6 September 2017

2

Shuwen Liu

1 reference

6 September 2017

Jie Yang

1

1 reference

PubMed ID

27061123

6 September 2017

language of work or name

1 reference

8 April 2016

1 reference

PubMed ID

27061123

Reviews in Medical Virology

6 September 2017

1 July 2016

1 reference

23 October 2022

2 references

6 September 2017

23 October 2022

26

1 reference

6 September 2017

242-250

1 reference

6 September 2017

4

1 reference

1918 Influenza: the mother of all pandemics

6 September 2017

1 reference

Antigenic and genetic characteristics of swine-origin 2009 A(H1N1) influenza viruses circulating in humans

21 January 2018

1 reference

Human influenza A H5N1 virus related to a highly pathogenic avian influenza virus

21 January 2018

1 reference

Airborne transmission of influenza A/H5N1 virus between ferrets

21 January 2018

1 reference

Human infection with a novel avian-origin influenza A (H7N9) virus

21 January 2018

1 reference

Novel reassortant influenza A(H5N8) viruses, South Korea, 2014.

21 January 2018

1 reference

Characterization of three H5N5 and one H5N8 highly pathogenic avian influenza viruses in China

21 January 2018

1 reference

Antiviral agents active against influenza A viruses.

21 January 2018

1 reference

Susceptibility of highly pathogenic A(H5N1) avian influenza viruses to the neuraminidase inhibitors and adamantanes.

21 January 2018

1 reference

Neuraminidase inhibitors for influenza

21 January 2018

1 reference

Incidence of adamantane resistance among influenza A (H3N2) viruses isolated worldwide from 1994 to 2005: a cause for concern

21 January 2018

1 reference

Comparison of central nervous system adverse effects of amantadine and rimantadine used as sequential prophylaxis of influenza A in elderly nursing home patients

21 January 2018

1 reference

Efficacy and safety of oseltamivir in treatment of acute influenza: a randomised controlled trial. Neuraminidase Inhibitor Flu Treatment Investigator Group.

21 January 2018

1 reference

Efficacy and safety of the neuraminidase inhibitor zanamivir in the treatment of influenzavirus infections. GG167 Influenza Study Group.

21 January 2018

1 reference

Post-marketing safety and effectiveness evaluation of the intravenous anti-influenza neuraminidase inhibitor peramivir (I): a drug use investigation

21 January 2018

1 reference

Clinical effectiveness of neuraminidase inhibitors--oseltamivir, zanamivir, laninamivir, and peramivir--for treatment of influenza A(H3N2) and A(H1N1)pdm09 infection: an observational study in the 2010-2011 influenza season in Japan.

21 January 2018

1 reference

Resistance of influenza viruses to neuraminidase inhibitors--a review.

21 January 2018

1 reference

Avian flu: isolation of drug-resistant H5N1 virus.

21 January 2018

1 reference

Dual resistance to adamantanes and oseltamivir among seasonal influenza A(H1N1) viruses: 2008-2010.

21 January 2018

1 reference

Functional balance between haemagglutinin and neuraminidase in influenza virus infections

21 January 2018

1 reference

Assembly and budding of influenza virus

21 January 2018

1 reference

Neuraminidase receptor binding variants of human influenza A(H3N2) viruses resulting from substitution of aspartic acid 151 in the catalytic site: a role in virus attachment?

21 January 2018

1 reference

Influenza Virus Neuraminidases with Reduced Enzymatic Activity That Avidly Bind Sialic Acid Receptors

21 January 2018

1 reference

Human H3N2 Influenza Viruses Isolated from 1968 To 2012 Show Varying Preference for Receptor Substructures with No Apparent Consequences for Disease or Spread

21 January 2018

1 reference

Recent H3N2 influenza virus clinical isolates rapidly acquire hemagglutinin or neuraminidase mutations when propagated for antigenic analyses

21 January 2018

1 reference

Comparison of mutation patterns in full-genome A/H3N2 influenza sequences obtained directly from clinical samples and the same samples after a single MDCK passage

21 January 2018

1 reference

The effect of the MDCK cell selected neuraminidase D151G mutation on the drug susceptibility assessment of influenza A(H3N2) viruses

21 January 2018

1 reference

A mutant influenza virus that uses an N1 neuraminidase as the receptor-binding protein

21 January 2018

1 reference

The neuraminidases of MDCK grown human influenza A(H3N2) viruses isolated since 1994 can demonstrate receptor binding.

21 January 2018

1 reference

Influenza virus neuraminidase: structure, antibodies, and inhibitors

21 January 2018

1 reference

Influenza A penetrates host mucus by cleaving sialic acids with neuraminidase.

21 January 2018

1 reference

Neuraminidase is important for the initiation of influenza virus infection in human airway epithelium

21 January 2018

1 reference

Roles of neuraminidase in the initial stage of influenza virus infection

21 January 2018

1 reference

Enhancement of the influenza A hemagglutinin (HA)-mediated cell-cell fusion and virus entry by the viral neuraminidase (NA).

21 January 2018

1 reference

NA proteins of influenza A viruses H1N1/2009, H5N1, and H9N2 show differential effects on infection initiation, virus release, and cell-cell fusion

21 January 2018

1 reference

Influenza viruses with receptor-binding N1 neuraminidases occur sporadically in several lineages and show no attenuation in cell culture or mice.

21 January 2018

1 reference

Association between adverse clinical outcome in human disease caused by novel influenza A H7N9 virus and sustained viral shedding and emergence of antiviral resistance

21 January 2018

1 reference

Global update on the susceptibility of human influenza viruses to neuraminidase inhibitors, 2013-2014.

21 January 2018

1 reference

Emergence of H274Y oseltamivir-resistant A(H1N1) influenza viruses in Japan during the 2008-2009 season

21 January 2018

1 reference

Detection of E119V and E119I mutations in influenza A (H3N2) viruses isolated from an immunocompromised patient: challenges in diagnosis of oseltamivir resistance

21 January 2018

1 reference

HIV entry inhibitors targeting gp41: from polypeptides to small-molecule compounds

21 January 2018

1 reference

21 January 2018

HIV entry inhibitors.

1 reference

Influenza A virus entry inhibitors targeting the hemagglutinin

21 January 2018

1 reference

Middle East respiratory syndrome coronavirus (MERS-CoV) entry inhibitors targeting spike protein.

21 January 2018

1 reference

Enfuvirtide, an HIV-1 fusion inhibitor, for drug-resistant HIV infection in North and South America

21 January 2018

1 reference

Identification of amino acids of influenza virus HA responsible for resistance to a fusion inhibitor, Stachyflin

21 January 2018

1 reference

CL-385319 inhibits H5N1 avian influenza A virus infection by blocking viral entry

21 January 2018

1 reference

A natural theaflavins preparation inhibits HIV-1 infection by targeting the entry step: potential applications for preventing HIV-1 infection

21 January 2018

1 reference

Structure-activity relationships of saponin derivatives: a series of entry inhibitors for highly pathogenic H5N1 influenza virus

21 January 2018

1 reference

Structure of the catalytic and antigenic sites in influenza virus neuraminidase

21 January 2018

1 reference

The neuraminidase of influenza virus

21 January 2018

1 reference

The structure of the complex between influenza virus neuraminidase and sialic acid, the viral receptor

21 January 2018

1 reference

The structure of H5N1 avian influenza neuraminidase suggests new opportunities for drug design.

21 January 2018

1 reference

21 January 2018

1 reference

Recent advances in the structure-based design of neuraminidase inhibitors as antiinfluenza agents

21 January 2018

1 reference

Serendipitous discovery of a potent influenza virus a neuraminidase inhibitor

21 January 2018

1 reference

From neuraminidase inhibitors to conjugates: a step towards better anti-influenza drugs?

21 January 2018

1 reference

Exploitation of the catalytic site and 150 cavity for design of influenza A neuraminidase inhibitors

21 January 2018

1 reference

Evidence for a sialosyl cation transition-state complex in the reaction of sialidase from influenza virus

21 January 2018

1 reference

Receptor specificity of influenza A H3N2 viruses isolated in mammalian cells and embryonated chicken eggs

21 January 2018

1 reference

Antiviral combinations for severe influenza.

21 January 2018

1 reference

The combination of ribavirin and ozeltamivir effectively inhibits reproduction of influenza A virus resistant to rimantadine (amantadine) in vitro and in vivo.

21 January 2018

1 reference

Triple combination of oseltamivir, amantadine, and ribavirin displays synergistic activity against multiple influenza virus strains in vitro.

21 January 2018

1 reference

Antiviral agents for the treatment and chemoprophylaxis of influenza --- recommendations of the Advisory Committee on Immunization Practices (ACIP).

21 January 2018

1 reference

12 December 2020

Search for novel neuraminidase inhibitors: Design, synthesis and interaction of oseltamivir derivatives with model membrane using docking, NMR and DSC methods.

1 reference

12 December 2020

Prevention and control of influenza. Recommendations of the Advisory Committee on Immunization Practices (ACIP).

1 reference

12 December 2020

Update: WHO-confirmed human cases of avian influenza A (H5N1) infection, November 2003-May 2008

1 reference

12 December 2020

Influenza A: understanding the viral life cycle

1 reference

12 December 2020

Site-directed mutagenesis of catalytic residues of influenza virus neuraminidase as an aid to drug design

1 reference

12 December 2020

Identifiers

DOI

10.1002/RMV.1879

1 reference

6 September 2017

0 references

1 reference

PubMed ID

27061123